SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

3 Months Ended

Mar. 31, 2013

Accounting Policies [Abstract]

Financial Instruments Where Carrying Value and Fair Value Differ

Fair Value of Financial Instruments
The following details our financial instruments where the carrying value and the fair value differ (amounts in millions):
		Fair Value at Reporting Date Using
Financial Instrument		As of March 31, 2013		Quoted Prices in Active Markets for Identical Items (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Long-term obligations	$	78.8	$	0	$	78.9	$	0

Weighted-Average Shares Outstanding

The following table sets forth, for the periods indicated, shares used in our computation of the weighted-average shares outstanding, which are used to calculate our basic and diluted net income attributable to Amedisys, Inc. common stockholders (amounts in thousands):

		For the Three-Month Periods Ended March 31,
		2013	2012
Weighted average number of shares outstanding - basic		30,640	29,389
Effect of dilutive securities:
	Stock options	21	16
	Non-vested stock and stock units	443	375
Weighted average number of shares outstanding - diluted		31,104	29,780
Anti-dilutive securities		220	340